• ETV5 as an Epigenetic Prognostic Marker in Cancer: Pan-Cance

  2026-05-05

  This study systematically characterizes ETV5 as a pan-cancer oncogenic transcription factor linked to adverse prognosis, drug resistance, and epigenetic regulation. It highlights the mechanistic interplay between ETV5 and EZH2-mediated histone methylation, offering new directions for targeted epigenetic therapies.

• Dual-Action p38α MAPK Inhibitors Accelerate Dephosphorylatio

  2026-05-05

  The referenced study uncovers how specific p38α MAPK inhibitors not only block kinase activity but also promote activation loop dephosphorylation by WIP1 phosphatase. This dual-action mechanism, supported by structural evidence, suggests new directions for the design of kinase inhibitors with improved potency and specificity in inflammation research.

• Degarelix Acetate: Predictive Biomarkers and Translational I

  2026-05-04

  Explore the profound utility of Degarelix acetate as a GnRH receptor antagonist in prostate cancer research. This article unveils new insights into testosterone kinetics as prognostic biomarkers, offering a differentiated perspective for advanced translational applications.

• SNS-032 (BMS-387032): Precision CDK Inhibition in Advanced A

  2026-05-04

  SNS-032 (BMS-387032) stands out as a precise, highly selective inhibitor of CDK2, CDK7, and CDK9, enabling researchers to interrogate cell cycle and transcriptional mechanisms in cancer and antiviral studies. This guide distills actionable workflows, advanced experimental setups, and troubleshooting strategies to maximize data quality and translational relevance.

• Lanabecestat (AZD3293): Optimizing BACE1 Inhibition in Alzhe

  2026-05-03

  Lanabecestat (AZD3293) empowers Alzheimer’s disease research with potent, brain-penetrant BACE1 inhibition and a synaptic-sparing profile at moderate exposures. This guide details streamlined workflows, troubleshooting tactics, and practical insights for reproducible modulation of amyloid-beta production in preclinical models.

• Auranofin as a Precision Tool for Metabolic Reprogramming in

  2026-05-02

  Explore Auranofin’s role as a thioredoxin reductase inhibitor for advanced cancer research. This article uniquely connects redox modulation with metabolic pathway targeting, offering practical protocols and new insights for oncology.

• FOXO3-Mediated Dual Metabolic Inhibition in Hepatocellular C

  2026-05-02

  This article dissects recent evidence identifying FOXO3 as a tumor suppressor that coordinately inhibits glycolysis and glutaminolysis in hepatocellular carcinoma (HCC) via transcriptional repression of YAP. The study's mechanistic insights reveal a promising avenue for metabolic intervention in HCC, highlighting both the innovation and the translational hurdles ahead.

• Ionizing Radiation Alters Neuronal Differentiation via PI3K-

  2026-05-01

  This study demonstrates that ionizing radiation (IR) drives altered neuronal differentiation in C17.2 mouse neural stem-like cells through the PI3K-STAT3-mGluR1 and PI3K-p53 signaling pathways. The findings have significant implications for understanding IR-induced brain dysfunction and for modeling neural differentiation in vitro.

• Gene Signatures in Mesothelioma Predict Olaparib and Pemetre

  2026-04-30

  Borchert et al. (2019) identified homologous recombination repair (HRR) gene expression patterns, including BRCAness and BAP1 mutations, as indicators of susceptibility to PARP inhibitor therapy in malignant pleural mesothelioma (MPM). Their findings lay the groundwork for precision chemotherapy research, including the strategic use of pemetrexed in combinatorial regimens targeting DNA repair vulnerabilities.

• Acifran Structural Insights Enable Precision Lipid Metabolis

  2026-04-30

  Explore how Acifran, a selective HM74A/GPR109A and GPR109B agonist, advances lipid metabolism research through cryo-EM–guided structural insights. This article uniquely connects Acifran’s molecular pharmacology to experimental design, setting it apart in the field.

• Hoechst 33258: Precision Bis-Benzimide DNA Staining in Tumor

  2026-04-29

  Hoechst 33258 offers unparalleled sensitivity for DNA staining in both live and fixed cells, empowering advanced analysis of tumor cell pH dynamics and cell cycle status. Its robust fluorescence and AT-rich DNA binding make it the gold standard for fluorescence microscopy and high-throughput flow cytometry in cancer research.

• EV-Transferred ACLY Drives TAM Differentiation in Liver Canc

  2026-04-29

  This study reveals that hepatocellular carcinoma (HCC) cells secrete extracellular vesicles loaded with ATP-citrate lyase (ACLY), which are selectively internalized by monocytes, driving their differentiation into immunosuppressive tumor-associated macrophages (TAMs). Targeting this EV-mediated ACLY transfer provides a mechanistically grounded strategy to enhance immunotherapy efficacy in HCC.

• Apicidin Impairs Oocyte Maturation by Disrupting Meiotic Mac

  2026-04-28

  This study reveals that Apicidin, a fungal mycotoxin and histone deacetylase inhibitor, compromises oocyte quality by disrupting spindle assembly, chromosome alignment, and histone acetylation. The findings highlight the dual role of Apicidin as both a research tool and an environmental contaminant with significant implications for reproductive toxicology and epigenetic research.

• Veratridine: Voltage-Gated Sodium Channel Opener for Researc

  2026-04-28

  Veratridine is a steroidal alkaloid neurotoxin and a potent voltage-gated sodium channel opener. It is widely used in sodium channel dynamics and excitotoxicity studies to model persistent depolarization and neuron injury, offering stable, reproducible effects. As supplied by APExBIO (SKU B7219), Veratridine is validated for precise assay integration in neuroscience and oncology research.

• Regulation of Progenitor Cells in Epithelial Morphogenesis

  2026-04-27

  This article examines Sophie Viala's 2024 doctoral thesis on the molecular regulation of progenitor cells during epithelial morphogenesis and homeostasis. The work delineates novel roles for Gata3 and BMP5 in prostate epithelial stem cell maintenance, with implications for tissue regeneration and tumorigenesis studies.

16630 records 1/1109 page Next 12345 下5页 Last page